Innovation

A Technique for the Visualization and Quantification of Aqueous Humor Outflow in the Eye

University of Pittsburgh
posted on 01/19/2012

Investigators have developed a technique for the non-invasive visualization and quantification of the primary pathway of aqueous humor outflow in the human eye.

Suggested Uses

  • Diagnosis of glaucoma

Advantages

  • First known technique to provide non-invasive direct measurement of aqueous outflow in the primary outflow pathway in the human eye

Innovation Details
 

Detailed Description

Volumetric circumferential scans of the limbus were obtained via SD-OCT (any scan containing structure and Doppler data will suffice). Scan data is then adjusted so that the gray scale presentation features outflow vessels as white structure on a dark background. A rolling ball background subtraction algorithm is then applied, and then contrast adjusted to isolate the outflow vessels. Individual processed volumes are stitched together to provide a perilimbal view of outflow structures. Terminal branches in the outflow vascular network are identified, and Doppler within those structures is measured. Doppler and cross-sectional assessments are combined to calculate flow in each terminal branch of the outflow network. Total aqueous humor outflow is determined by integrating flow across all identified terminal outflow structures.

Stage of Development
Software code written and successfully tested in vitro

Provisional Patent Application filed

File Number: 2476 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Brian Copple at University of Pittsburgh for more information.

Request more info via email request more info
People

Case Manager:

Brian Copple Brian Copple

Innovations (64)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...